Philip Toleikis
Corporate Officer/Principal at Medway Working Group
Net worth: 2 M $ as of 2024-04-29
Philip Toleikis active positions
| Companies | Position | Start | End |
|---|---|---|---|
| Medway Working Group | Corporate Officer/Principal | - | - |
Career history of Philip Toleikis
Former positions of Philip Toleikis
| Companies | Position | Start | End |
|---|---|---|---|
| SERNOVA CORP. | Director/Board Member | 2010-10-18 | 2024-04-29 |
| Chief Executive Officer | 2009-04-27 | 2023-09-04 | |
| Chief Tech/Sci/R&D Officer | 2023-09-04 | 2024-04-29 | |
| Investor Relations Contact | - | 2014-07-27 | |
| Public Communications Contact | 2010-10-18 | 2014-07-27 | |
| President | 2009-04-27 | 2023-09-04 | |
Angiotech Pharmaceuticals, Inc.
 Angiotech Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology Angiotech Pharmaceuticals, Inc. is a global specialty pharmaceutical and medical device company, which engages in developing, manufacturing and marketing medical products and technologies, within the areas of interventional oncology, wound closure and ophthalmology. The company was founded by William L. Hunter and Cruz F. Tony in 1992 and is headquartered in Vancouver, Canada. | Chief Tech/Sci/R&D Officer | 2005-12-31 | 2005-12-31 |
Training of Philip Toleikis
| University of British Columbia | Doctorate Degree |
| University of Michigan | Graduate Degree |
| University of Vermont | Undergraduate Degree |
Statistics
International
| Canada | 5 |
| United States | 3 |
Operational
| Chief Tech/Sci/R&D Officer | 2 |
| Doctorate Degree | 1 |
| Graduate Degree | 1 |
Sectoral
| Consumer Services | 4 |
| Health Technology | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| SERNOVA CORP. | Health Technology |
| Private companies | 2 |
|---|---|
Angiotech Pharmaceuticals, Inc.
Angiotech Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology Angiotech Pharmaceuticals, Inc. is a global specialty pharmaceutical and medical device company, which engages in developing, manufacturing and marketing medical products and technologies, within the areas of interventional oncology, wound closure and ophthalmology. The company was founded by William L. Hunter and Cruz F. Tony in 1992 and is headquartered in Vancouver, Canada. | Health Technology |
| Medway Working Group |
- Stock Market
- Insiders
- Philip Toleikis
- Experience
